Q3 2025 Holdings
Filed 2025-11-13 | 9 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $578.7M | 16,707,477 | 32.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $551.8M | 6,720,803 | 30.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $427.4M | 31,424,760 | 23.9% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $115.3M | 4,505,391 | 6.4% |
| Merus N V | COM | N5749R100 | $42.6M | 452,527 | 2.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $40.8M | 4,854,443 | 2.3% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $24.8M | 4,126,119 | 1.4% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.7M | 9,105,451 | 0.4% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $2.4M | 5,319,148 | 0.1% |